Bioelectronics Corporation
BIEL
Rank in Stocks
#29599
BioElectronics Corporation, an electroceutical company, engages in the... BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.
Share Price
$0.0003
Last synced: 2026-11-09
Market Cap
$7.41M
Change (1 day)
0.00%
Change (1 year)
-25.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bioelectronics Corporation (BIEL)
Category
Healthcare
EPS for Bioelectronics Corporation (BIEL)
EPS as of March 2023 TTM: 0.00
According to Bioelectronics Corporation's latest financial reports, its current EPS (TTM) is 0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Bioelectronics Corporation from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | 0.00% |
| 2021 | 0.00 | 0.00% |
| 2020 | 0.00 | -100.00% |
| 2019 | 0.00 | -50.00% |
| 2018 | 0.00 | 100.00% |
| 2017 | 0.00 | -50.00% |
| 2016 | 0.00 | -33.33% |
| 2015 | 0.00 | -50.00% |
| 2014 | 0.00 | -14.29% |
| 2013 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.45 | - |
IE
|
|
| $0.21 | - |
CN
|
|
| $19.69 | - |
CH
|
|
| $4.34 | - |
CH
|
|
| $0.13 | - |
CN
|
Questions about Bioelectronics Corporation's earnings per share (EPS)
What was Bioelectronics Corporation's earnings per share (EPS) in 2025?
In 2025, Bioelectronics Corporation's earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Bioelectronics Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Bioelectronics Corporation's earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).
How does Bioelectronics Corporation's earnings per share (EPS) compare with similar companies?
Bioelectronics Corporation's earnings per share (EPS) (0.00) is lower than that of all 5 similar companies listed above. The highest among them is Ypsomed Holding AG, with $19.69.